Company Name: |
GLP Pharma Standards
|
Tel: |
+91 9866074638 |
Email: |
info@glppharmastandards.com |
Products Intro: |
Product Name:Ritonavir EP Impurity-H CAS:1010809-43-4 Purity:98% Package:50 MG; 100 MG; 250 MG ; 1 GM
|
|
| (4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoiMidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylMethyl Ester Basic information |
Product Name: | (4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoiMidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylMethyl Ester | Synonyms: | Des(isopropylthiazolyl) Hydantoin-oxazolidinone Ritonavir;(4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoiMidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylMethyl Ester;(4S,5S)-5-[(2S)-2-[(4S)-4-(1-Methylethyl)-2;Ritonavir IMpurity H;(4S,5S)-5-[(2S)-2-[(4S)-4-(1-Methylethyl)-2,5-dioxo-1-imidazolidinyl]-3-phenylpropyl]-2-oxo-4-(phenylmethyl)-3-oxazolidinecarboxylic acid 5-thiazolylmethyl ester;Ritonavir EP Impurity H;Ritonavir Impurity 8(Ritonavir EP Impurity H);Ritonavir EP IMP H | CAS: | 1010809-43-4 | MF: | C30H32N4O6S | MW: | 576.66 | EINECS: | | Product Categories: | Aromatics, Chiral Reagents, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds;Aromatics;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds | Mol File: | 1010809-43-4.mol | |
| (4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoiMidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylMethyl Ester Chemical Properties |
density | 1.321±0.06 g/cm3(Predicted) | pka | 8.40±0.70(Predicted) |
| (4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoiMidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylMethyl Ester Usage And Synthesis |
Uses | Des(isopropylthiazolyl) Hydantoin-oxazolidinone Ritonavir (Ritonavir EP Impurity H) is a Ritonavir (R535000) derivative with potential use in the treatment of viral infections. Cytochrome P450 oxidase inhibitor. It is a COVID19-related research product. | Uses | As Ritonavir (R535000) derivative with potential (4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoiMidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylMethyl Ester can be used in the treatment of viral infections. |
| (4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoiMidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylMethyl Ester Preparation Products And Raw materials |
|